Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/26/2008EP1995243A1 Triazole derivative or salt thereof
11/26/2008EP1995241A1 Inhibitors of ion channels
11/26/2008EP1995240A1 Quinolone derivative or pharmaceutically acceptable salt thereof
11/26/2008EP1995238A2 Novel tetrahydrocarbazole derivatives with improved biological action and improved solubility as ligands for g-protein coupled receptors (GPCRS)
11/26/2008EP1994934A1 Therapeutic agent for degenerative arthritis
11/26/2008EP1994933A1 Aqueous composition
11/26/2008EP1994932A1 Use of N-desmethylclozapine to treat human psychosis
11/26/2008EP1994931A1 Prophylactic or therapeutic agent for allergic ophthalmic disease or allergic nasal disease comprising tricyclic triazolobenzoazepine derivative
11/26/2008EP1994930A1 Triazol compounds for treating biofilm formation
11/26/2008EP1994929A1 Use of derivatives of naphthalenesulphonic or quinolinesulphonic acid in the treatment of vasoproliferative ocular diseases
11/26/2008EP1994928A1 Antimicrobial agent and antimicrobial composition
11/26/2008EP1994927A1 Diamondoid derivatives possessing therapeutic activity in the treatment of viral disorders
11/26/2008EP1994926A1 Valsartan formulations
11/26/2008EP1994925A1 Taxane pharmaceutical formulation, solid taxane composition, method for preparing the solid taxane composition, composition for solubilising said solid taxane composition and set of elements (kit) for the injectable taxane formulation
11/26/2008EP1994837A2 Plant derived or derivable material with appetite suppressant activity
11/26/2008EP1994491A2 Flavivirus inhibition by sultams and related compounds
11/26/2008EP1994184A2 Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics
11/26/2008EP1994176A2 Methods and agents for modulating an immune response
11/26/2008EP1994155A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling
11/26/2008EP1994152A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/26/2008EP1994146A1 Cancerous disease modifying antibody 141205-02
11/26/2008EP1994081A1 Novel poly(ethylene oxide)-block-poly(ester) block copolymers
11/26/2008EP1994062A1 Aryl/alkyl vinyl sulfone hyaluronic acid derivatives
11/26/2008EP1994044A2 DERIVATIVES OF 18ß-GLYCYRRHETINIC ACID
11/26/2008EP1994042A2 Preparation of gemcitabine
11/26/2008EP1994033A1 Indolopyridines as eg5 kinesin modulators
11/26/2008EP1994032A1 Pyrazole derivatives as sigma receptor inhibitors
11/26/2008EP1994031A1 Use of adenosine a1 and/or dual a1/a2b agonists for production of medicaments for treating diseases
11/26/2008EP1994030A1 Multi-cyclic compounds and method of use
11/26/2008EP1994029A2 Potassium channel inhibitors
11/26/2008EP1994028A1 Quinoline derivatives for treating cancer
11/26/2008EP1994023A1 Quinazoline derivatives
11/26/2008EP1994022A2 N-substituted-azacyclylamines as histamine-3 antagonists
11/26/2008EP1994020A2 Substituted quinolones iii
11/26/2008EP1994019A2 Novel piperidin - substituted indoles and their use as ccr-3 modulators
11/26/2008EP1994016A2 5-phenyl-3-benzyl-oxazolidin-2-one derivatives and related compounds as metabotropic glutamate receptor potentiators for the treatment of neurological and psychiatric disorders
11/26/2008EP1994015A1 Dibenzyl amine derivatives as cetp inhibitors
11/26/2008EP1994010A1 Compounds which inhibit the glycine transporter and uses thereof
11/26/2008EP1994009A1 4-amino-1,5-substituted 1,5-dihydro-imidazol-2-ones
11/26/2008EP1994008A2 Imidazole compounds having pharmaceutical activity towards the sigma receptor
11/26/2008EP1994005A1 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
11/26/2008EP1994004A2 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors
11/26/2008EP1994003A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them .
11/26/2008EP1994002A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them
11/26/2008EP1994000A2 Water-soluble cc-1065 analogs and their conjugates
11/26/2008EP1993999A1 Improved prodrugs of cc-1065 analogs
11/26/2008EP1993997A2 Diphenyl urea derivatives
11/26/2008EP1993995A1 Amino acid derivatives
11/26/2008EP1993994A2 Deuterated hepatitis c protease inhibitors
11/26/2008EP1993716A1 Method of preparing a pulverulent composition and product as obtained
11/26/2008EP1993673A2 Injectable combination therapy for eye disorders
11/26/2008EP1993611A2 RNAi MODULATION OF TGF-BETA AND THERAPEUTIC USES THEREOF
11/26/2008EP1993609A2 Agent-enriched nanoparticles based on hydrophilic proteins
11/26/2008EP1993591A2 Targeted delivery of pharmaceutical compounds
11/26/2008EP1993588A2 Tissue adhesives and sealants and methods for their use
11/26/2008EP1993586A2 Method for treating peripheral arterial disease with zinc finger proteins
11/26/2008EP1993583A2 Inhibitors of membrane type-1 matrix metalloproteinase for the treatment of insulin-dependent diabetes mellitus
11/26/2008EP1993581A1 Novel use of ubiquitin c-terminal hydrolase-l1
11/26/2008EP1993579A2 A pharmaceutical composition for the prevention/treatment of bone disorders and a process for the preparation thereof
11/26/2008EP1993577A2 Use of non-digestable sacharides for giving an infant the best start after birth
11/26/2008EP1993566A1 Protease inhibitor for wound treatment
11/26/2008EP1993564A1 Method and composition for treating allergic diseases
11/26/2008EP1993563A2 Pharmaceutical latrunculin formulations
11/26/2008EP1993562A2 A novel non-selective cation channel in neuronal cells and methods for treating brain swelling
11/26/2008EP1993561A2 Trpm2-specific inhibitors
11/26/2008EP1993560A2 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
11/26/2008EP1993559A2 Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
11/26/2008EP1993558A2 Oxysterol compounds and the hedgehog pathway
11/26/2008EP1993557A2 Novel epoprostenol formulation and method of making thereof
11/26/2008EP1993556A1 An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms
11/26/2008EP1993555A1 Composition containing amidine derivatives or carboxamide derivatives and steroids, as a medicament
11/26/2008EP1993553A1 Methods for cancer therapy and stem cell modulation
11/26/2008EP1993552A2 Use of pyrazolo[1,5a]pyrimidin-7-yl amine derivatives in the treatment of neurological disorders
11/26/2008EP1993551A2 Potassium channel inhibitors
11/26/2008EP1993550A1 Gsk-3 inhibitors for the treatment of osteoporosis
11/26/2008EP1993549A1 Medicament formulations comprising fluoroquinolones
11/26/2008EP1993548A2 Compounds for inhibiting beta-amyloid production
11/26/2008EP1993547A2 Prodrugs of benzoquinolizine-2-carboxylic acid
11/26/2008EP1993545A2 Spray dispensers
11/26/2008EP1993544A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain
11/26/2008EP1993543A2 Novel crystalline forms of antidiabetic compounds
11/26/2008EP1993542A1 Method of treating inflammatory skin diseases using tropisetron, and pharmaceutical compositions thereof
11/26/2008EP1993541A2 Antihypertensive therapy
11/26/2008EP1993540A2 Compositions and methods for the treatment of immunoinflammatory disorders
11/26/2008EP1993539A2 Thiazolones for use as pi3 kinase inhibitors
11/26/2008EP1993538A2 Thiazolones for use as pi3 kinase inhibitors
11/26/2008EP1993537A2 Thiazolones for use as pi3 kinase inhibitors
11/26/2008EP1993536A2 Thiazolones for use as pi3 kinase inhibitors
11/26/2008EP1993535A2 Thiazolones for use as pi3 kinase inhibitors
11/26/2008EP1993534A1 Use of light-active indocyanine green for treating inflammatory disorders in the oral cavity
11/26/2008EP1993533A2 Use of nefopam for the treatment of affective disorders
11/26/2008EP1993532A2 Treatment of atherosclerotic disease
11/26/2008EP1993531A2 Extended cycle multiphasic oral contraceptive method
11/26/2008EP1993530A2 Use of dha and ara in the preparation of a composition for regulating gene expression
11/26/2008EP1993529A1 Alpha-2-delta ligands for non-restorative sleep
11/26/2008EP1993528A2 Treatment modalities for autoimmune diseases
11/26/2008EP1993527A2 Inhibiting amyloid-beta peptide/rage interaction at the blood-brain barrier
11/26/2008EP1993526A2 Epinephrine dosing regimens
11/26/2008EP1993525A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain
11/26/2008EP1993524A1 The use of bupropion metabolites for the treatment of inflammatory disorders
1 ... 2979 2980 2981 2982 2983 2984 2985 2986 2987 2988 2989 2990 2991 2992 2993 2994 2995 2996 2997 2998 2999 ... 7860